期刊论文详细信息
Bratislava Medical Journal
Improvement in cardiovascular risk markers by the combined effect of natural polyphenols and vitamins in patients after kidney transplantation
article
Zuzana SZENTESIOVA1  Branislav TREBATICKY2  Zuzana ZILINSKA2  Jan BREZA2  Stanislav ORAVEC4  Zuzana ORSZAGHOVA1  Jana MUCHOVA1 
[1] Institute of Medical Chemistry, Biochemistry and Clinical Biochemistry, Faculty of Medicine, Comenius University;Department of Urology with Center for Kidney Transplantations, Faculty of Medicine, University Hospital;5th Department of Internal Medicine, Faculty of Medicine, University Hospital Bratislava;Department of Internal Medicine, Faculty of Medicine, Comenius University
关键词: kidney transplantation;    lipoprotein subfractions;    Lipoprint System;    Pycnogenol;   
DOI  :  10.4149/BLL_2022_041
学科分类:医学(综合)
来源: AEPress, s.r.o.
PDF
【 摘 要 】

OBJECTIVES: The aim of this study was to evaluate the potential of supportive therapy by natural polyphenols combined with vitamins C and E on kidney function and risk factors of cardiovascular diseases in renal transplant recipients (RTR).BACKGROUND: Transplant patients have an altered lipid profile associated with the development of cardiovascular disease, which is a major cause of graft loss and mortality in patients.METHODS: The study included 29 renal transplant recipients with mean graft function levels. The lipoprotein (atherogenic and non-atherogenic) subfractions were identified and quantified in plasma by polyacrylamide gel electrophoresis.RESULTS: After supplementation, glomerular filtration rate (GFR) was increased by 8 %, serum creatinine was decreased by 6.7 % and significant changes were found in atherogenic LDL subfractions. The effect of supplementation was observed in arylesterase and lactonase activities of paraoxonase 1 which increased by 9.3 % and 8.1 %, respectively. In addition, significantly decreased levels of neopterin (by 16 %) and asymmetric dimethylarginine (ADMA) (by 7.9 %) were found.CONCLUSION: We could summarize that supportive therapy improves the renal function (GFR, serum creatinine), and reduces the risk of cardiovascular disease by affecting important risk markers of atherosclerosis (lipid profile, paraoxonase 1 activity, neopterin and ADMA) in RTR (Tab. 4, Fig. 1, Ref. 53).

【 授权许可】

CC BY   

【 预 览 】
附件列表
Files Size Format View
RO202306290000112ZK.pdf 196KB PDF download
  文献评价指标  
  下载次数:15次 浏览次数:1次